Giorgio Sesti

Q: What Schools Are Affiliated With Giorgio Sesti

Giorgio Sesti is affiliated with the following schools: University of Milan, Stanford University, University of Palermo, Magna Græcia University, Sapienza University of Rome

Giorgio Sesti's AcademicInfluence.com Rankings

Giorgio Sesti

Physics

#7474

World Rank

#9507

Historical Rank

physics Degrees

Download Badge

Physics

Giorgio Sesti's Degrees

PhD Physics University of Milan
Masters Physics University of Milan
Bachelors Physics University of Milan

Why Is Giorgio Sesti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giorgio Sesti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) (2009) (1429)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells (2002) (359)
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders (2001) (357)
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. (2001) (343)
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. (2005) (281)
Uric acid and endothelial dysfunction in essential hypertension. (2006) (194)
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. (2017) (193)
Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents (2010) (178)
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. (2005) (170)
Pathophysiology of insulin resistance. (2006) (164)
Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser312 and Ser616 in Human Umbilical Vein Endothelial Cells (2004) (164)
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. (2005) (160)
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study (2008) (155)
The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. (1999) (154)
Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential (2000) (154)
The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. (2006) (151)
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. (2003) (150)
Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals (2008) (148)
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. (2009) (146)
Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. (1994) (137)
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes (2015) (136)
Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. (2003) (129)
Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials (2017) (128)
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient (2002) (126)
Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. (2002) (126)
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. (2004) (125)
High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects (2014) (119)
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—the EUGENE2 study (2008) (119)
Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-&kgr;B Signaling Pathway in HepG2 Cells (2017) (116)
G972R IRS-1 Variant Impairs Insulin Regulation of Endothelial Nitric Oxide Synthase in Cultured Human Endothelial Cells (2004) (115)
Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. (1994) (113)
Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. (2003) (111)
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. (2013) (108)
The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. (2005) (108)
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus. (2009) (108)
C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport (2007) (108)
Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. (2004) (107)
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity (2020) (107)
Endothelial Dysfunction and Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients (2010) (107)
Heterogeneous Effect of Peroxisome Proliferator‐activated Receptor γ2 Ala12 Variant on Type 2 Diabetes Risk (2007) (107)
Interleukin-6 Impairs the Insulin Signaling Pathway, Promoting Production of Nitric Oxide in Human Umbilical Vein Endothelial Cells (2007) (103)
Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues (1997) (99)
The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. (2000) (98)
The common Arg972 polymorphism in insulin receptor substrate‐1 causes apoptosis of human pancreatic islets (2001) (95)
One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. (2015) (93)
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. (2005) (93)
Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms (2001) (92)
Variants of the Interleukin-10 Promoter Gene Are Associated With Obesity and Insulin Resistance but Not Type 2 Diabetes in Caucasian Italian Subjects (2006) (92)
Increased O‐glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic β‐cells (2004) (91)
Altered Insulin Receptor Signalling and β-Cell Cycle Dynamics in Type 2 Diabetes Mellitus (2011) (88)
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. (2010) (85)
Review of Methods for Detecting Glycemic Disorders. (2020) (85)
One-Hour Postload Plasma Glucose Levels and Left Ventricular Mass in Hypertensive Patients (2011) (84)
Endothelial Dysfunction and C-Reactive Protein Are Risk Factors for Diabetes in Essential Hypertension (2008) (84)
Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. (2011) (83)
The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. (2012) (79)
Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. (2008) (77)
One-hour postload plasma glucose levels are associated with kidney dysfunction. (2010) (77)
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus (2015) (76)
Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile (2015) (76)
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release (2014) (75)
Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. (1996) (75)
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. (2004) (74)
Cardiometabolic Risk Profiles and Carotid Atherosclerosis in Individuals With Prediabetes Identified by Fasting Glucose, Postchallenge Glucose, and Hemoglobin A1c Criteria (2012) (73)
Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. (2004) (72)
Insulin Sensitivity, β-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels (2012) (70)
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects (2017) (69)
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN β‐cell line and human islets of Langerhans (2003) (69)
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics (2010) (68)
Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women (2007) (67)
Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. (2004) (66)
Endogenous testosterone and endothelial function in postmenopausal women (2007) (66)
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. (2003) (65)
A Candidate Type 2 Diabetes Polymorphism Near the HHEX Locus Affects Acute Glucose-Stimulated Insulin Release in European Populations (2008) (64)
Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients (1997) (64)
Variant near ADAMTS9 Known to Associate with Type 2 Diabetes Is Related to Insulin Resistance in Offspring of Type 2 Diabetes Patients—EUGENE2 Study (2009) (63)
Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. (1998) (62)
Components of the Metabolic Syndrome and Carotid Atherosclerosis: Role of Elevated Blood Pressure (2005) (62)
Association between One-Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension (2012) (62)
Role of C Reactive Protein (CRP) in Leptin Resistance (2014) (61)
The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. (2009) (61)
Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. (2009) (60)
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. (2013) (60)
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance (2011) (59)
Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. (2009) (59)
Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L). (2018) (58)
Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage (2019) (58)
Expression of Insulin/IGF-I Hybrid Receptors Is Increased in Skeletal Muscle of Patients With Chronic Primary Hyperinsulinemia (1998) (57)
Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects (2008) (57)
Effects of Weight Loss in Metabolically Healthy Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet (2011) (55)
TRIB3 R84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells (2008) (54)
Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. (2005) (53)
Molecular and Functional Characterization of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38)/Vasoactive Intestinal Polypeptide Receptors in Pancreatic β-Cells and Effects of PACAP-38 on Components of the Insulin Secretory System1. (1999) (52)
Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure (2017) (52)
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine (2019) (52)
Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. (1991) (52)
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials (2017) (51)
Altered pattern of insulin receptor isotypes in skeletal muscle membranes of Type 2 (non-insulin-dependent) diabetic subjects (1993) (48)
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice (2016) (48)
Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver Disease (2014) (48)
The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes (2006) (48)
Plasma Interleukin-6 Levels Are Independently Associated With Insulin Secretion in a Cohort of Italian-Caucasian Nondiabetic Subjects (2006) (47)
Individualized Therapy for Type 2 Diabetes (2012) (46)
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects (2014) (46)
Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus. (1997) (46)
Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program. (2011) (45)
One-Hour Postload Plasma Glucose Levels and Diastolic Function in Hypertensive Patients (2011) (45)
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials (2017) (44)
Plasma interleukin‐6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians (2007) (43)
Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. (2008) (43)
The UCP2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis. (2015) (43)
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method. (2019) (43)
Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? (2002) (42)
The Gly972-->Arg IRS-1 variant is associated with type 1 diabetes in continental Italy. (2003) (42)
Modulation of insulin secretion by diazepam binding inhibitor and its processing products (1991) (42)
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism (2016) (41)
Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals (2017) (41)
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. (2007) (41)
Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells (1996) (41)
Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. (1988) (41)
Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene. (2004) (40)
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus (2019) (39)
The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents. (2018) (39)
Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease (2014) (39)
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. (2019) (38)
Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis (2014) (38)
Serum Uric Acid and 1-h Postload Glucose in Essential Hypertension (2011) (38)
Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. (2013) (38)
Molecular and cellular characterization of the GABAA receptor in the rat pancreas (1994) (37)
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials. (2020) (37)
Mechanisms linking empagliflozin to cardiovascular and renal protection. (2017) (36)
Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. (2005) (36)
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials. (2017) (35)
Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. (1999) (35)
One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes (2018) (35)
Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients (2007) (34)
A Fasting Insulin–Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity (2013) (34)
One-hour post-load plasma glucose levels are associated with elevated liver enzymes. (2011) (33)
Uric Acid Impairs Insulin Signaling by Promoting Enpp1 Binding to Insulin Receptor in Human Umbilical Vein Endothelial Cells (2018) (33)
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden. (2016) (33)
Effect of insulin on hydrogen peroxide production by human polymorphonuclear leukocytes. Studies with monoclonal anti-insulin receptor antibodies, and an agonist and an inhibitor of protein kinase C. (1995) (33)
The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects. (2011) (32)
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. (2013) (32)
Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. (2011) (31)
IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. (2011) (31)
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia (2017) (31)
Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)/vasoactive intestinal polypeptide receptors in pancreatic beta-cells and effects of PACAP-38 on components of the insulin secretory system. (1999) (31)
Oxidative stress impairs endothelial function in nondipper hypertensive patients. (2012) (31)
IL-18 gene polymorphism and metabolic syndrome. (2009) (30)
IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variants (2009) (30)
Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold (2007) (30)
Serum Alkaline Phosphatase Negatively Affects Endothelium-Dependent Vasodilation in Naïve Hypertensive Patients (2015) (30)
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile (2014) (30)
Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B (2011) (30)
Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. (2013) (30)
Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study (2018) (30)
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. (2011) (29)
Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. (2011) (29)
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) (2021) (29)
PCSK9 inhibitor therapy: A systematic review and meta‐analysis of metabolic and cardiovascular outcomes in patients with diabetes (2019) (29)
Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion. (2008) (29)
Evidence That Two Naturally Occurring Human Insulin Receptor α-Subunit Variants Are Immunologically Distinct (1992) (28)
Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome. (2005) (28)
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. (2003) (28)
Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. (2008) (28)
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity. (2017) (27)
Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients (2012) (27)
Insulin receptor substrate polymorphisms and type 2 diabetes mellitus. (2000) (27)
Management of diabetes in older adults. (2017) (27)
PTP1B deficiency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes. (2008) (27)
Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. (2010) (27)
Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients (2020) (26)
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. (2017) (26)
CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project (2015) (26)
Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension. (2017) (26)
Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels (2013) (26)
Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians. (2012) (26)
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals (2017) (25)
Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects (2010) (25)
Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein (1994) (25)
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals (2018) (24)
Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women. (2007) (24)
Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model (2020) (24)
Uric acid is an independent predictor of cardiovascular events in post-menopausal women. (2015) (24)
Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors. (2014) (24)
Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women. (2007) (24)
Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients (2016) (24)
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report (2020) (24)
Ketogenic Diet-Induced Weight Loss is Associated with an Increase in Vitamin D Levels in Obese Adults (2019) (24)
SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction. (2015) (23)
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. (2014) (23)
One‐hour post‐load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross‐sectional data from the CATAMERI study (2018) (23)
One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects. (2016) (23)
Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%. (2013) (22)
Large brachial and common carotid artery diameter in postmenopausal women with carotid atherosclerosis. (2008) (22)
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials (2017) (22)
Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding (2009) (22)
An extracellular domain of the insulin receptor beta-subunit with regulatory function on protein-tyrosine kinase. (1989) (22)
Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance (2020) (22)
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells. (2011) (21)
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis (2022) (21)
A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity (2012) (21)
Nutrition, Metabolism & Cardiovascular Diseases (2014) (21)
Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? (2020) (20)
Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension (1996) (20)
Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells (1992) (20)
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. (2017) (20)
New insights into body composition assessment in obese women. (1999) (19)
Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor (1995) (19)
Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance (2020) (19)
Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. (2014) (19)
Insulin-resistance HCV infection-related affects vascular stiffness in normotensives. (2015) (19)
Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies (2008) (18)
The sulfonylurea glimepiride regulates intracellular routing of the insulin-receptor complexes through their interaction with specific protein kinase C isoforms. (2001) (18)
Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients. (2014) (18)
Quantitative analysis of pancreatic glucokinase gene expression in cultured β cells by competitive polymerase chain reaction (1996) (18)
Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients (2009) (18)
G 972 R IRS-1 Variant Impairs Insulin Regulation of Endothelial Nitric Oxide Synthase in Cultured Human Endothelial Cells (2004) (17)
TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion (2010) (17)
Metabolic Syndrome (2015) (16)
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity (2017) (16)
Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance (2011) (16)
Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women (2009) (16)
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes. (2020) (16)
Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals. (2015) (16)
in IRS-1 impairs insulin secretion in pancreatic β cells (1999) (16)
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in Italy (2020) (16)
Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation. (2007) (15)
Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects. (1989) (15)
Relation of fasting insulin related to insertion/deletion polymorphism of angiotensin-converting enzyme-gene and cardiac mass in never-treated patients with systemic hypertension. (2003) (15)
Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis. (2013) (15)
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis (2021) (15)
Insulin receptor variant forms and type 2 diabetes mellitus. (2000) (15)
Vitamin D and 1-hour post-load plasma glucose in hypertensive patients (2014) (15)
Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes. (2007) (14)
Searching for type 2 diabetes genes: prospects in pharmacotherapy (2002) (14)
Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status (2019) (14)
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria (2015) (14)
Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance (2020) (14)
Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects (2021) (13)
Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies (1994) (13)
Experiences on quantitative cardiac PET analysis (2016) (13)
The effects of pregnancy steroids on adaptation of beta cells to pregnancy involve the pancreatic glucose sensor glucokinase. (1997) (13)
Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world (2020) (13)
The Arg 972 Variant in Insulin Receptor Substrate-1 Is Associated With an Increased Risk of Secondary Failure to Sulfonylurea in Patients With Type 2 Diabetes (2004) (13)
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects (2020) (13)
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
HDL cholesterol is an independent predictor of β‐cell function decline and incident type 2 diabetes: A longitudinal study (2020) (12)
Endothelial dysfunction predicts regression of hypertensive cardiac mass. (2013) (12)
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis (2018) (12)
Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? (2019) (12)
Association of Insulin Resistance Indexes to Carotid Intima–Media Thickness (2013) (12)
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. (2017) (11)
One‐hour post‐load plasma glucose and IGF‐1 in hypertensive patients (2012) (11)
Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects (1996) (11)
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study (2021) (11)
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond (2021) (11)
Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. (2017) (11)
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases (2016) (11)
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9) (2020) (11)
Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (2010) (11)
A polymorphism at IGF1 locus is associated with anemia (2017) (10)
Differences in cardiovascular risk profile based on relationship between post‐load plasma glucose and fasting plasma levels (2009) (10)
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect (2020) (10)
Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation (2019) (10)
Relative Risk of Cardiovascular Disease Is Higher in Women With Type 2 Diabetes, but Not in Those With Prediabetes, as Compared With Men (2020) (10)
Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors (2016) (10)
Gly460Trp α-adducin gene polymorphism and endothelial function in untreated hypertensive patients (2007) (10)
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival (2020) (10)
GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea (1999) (10)
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy (2020) (10)
The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals. (2008) (10)
Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation (2014) (10)
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance (2020) (10)
Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics. (2019) (10)
Phenotypic characterization of normotolerant hypertensive patients. (2013) (9)
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C. (2014) (9)
The common Arg 972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets (2000) (9)
Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. (2005) (9)
Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiency (2020) (9)
Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss (2009) (9)
Cardiometabolic Risk Pro fi les and Carotid Atherosclerosis in Individuals With Prediabetes Identi fi ed by Fasting Glucose , Postchallenge Glucose , and Hemoglobin A 1 c Criteria (2012) (9)
Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects (2006) (9)
DBI mRNA is expressed in endocrine pancreas and its post-translational product DBI33–50 inhibits insulin release (1995) (9)
Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients. (2016) (9)
Insulin clearance is associated with carotid artery intima-media thickness. (2013) (9)
Predictors of Renal Function Worsening in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Multicenter Observational Study (2021) (9)
Endothelial dysfunction and C‐reactive protein predict the incidence of heart failure in hypertensive patients (2020) (9)
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age (2020) (9)
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus (2017) (8)
Are Circulating Mg 2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? (2019) (8)
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women (2021) (8)
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction (2017) (8)
Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index (2019) (8)
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. (2013) (8)
Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement (2019) (8)
Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes. (2015) (8)
GRB10 gene and type 2 diabetes in Whites (2010) (7)
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis Of Randomized Controlled Trials. (2020) (7)
Correspondence Between the International Diabetes Federation Criteria for Metabolic Syndrome and Insulin Resistance in a Cohort of Italian Nondiabetic Caucasians (2007) (7)
Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects. (2020) (7)
Characterization of left ventricular mass in individuals at risk for type 2 diabetes identified by HbA1c levels according to the American Diabetes Association criteria. (2015) (7)
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. (2011) (7)
Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions. (2016) (7)
Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice (2019) (7)
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice (2020) (7)
Insulin-like growth factor-1 is a negative modulator of glucagon secretion. (2017) (7)
Creatinine and insulin predict cardiac mass in drug-naïve hypertensive patients. (2013) (7)
Multiplicative effect of serum phosphorus levels and insulin resistance on hypertensive vascular stiffness (2016) (7)
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients (2019) (6)
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study (2022) (6)
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care (2021) (6)
3′-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients (2014) (6)
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. (2008) (6)
Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation. (2017) (6)
Dietary patterns and 1-h post-load glucose in essential hypertension. (2014) (6)
HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion (2020) (6)
COPD significantly increases cerebral and cardiovascular events in hypertensives (2021) (6)
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care 2008;31:1886–1888 (2012) (6)
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines (2021) (6)
Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients (2019) (6)
The SH2B1 obesity locus and abnormal glucose homeostasis: lack of evidence for association from a meta-analysis in individuals of European ancestry. (2013) (6)
Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study (2018) (6)
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial (2022) (5)
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents (2019) (5)
Attenuated by Interaction with C Reactive Protein. (2009) (5)
Endothelial Dysfunction and CRP Are Risk Factors for Diabetes in Essential Hypertension (2007) (5)
Cardiovascular effects of glucagon‐like peptide‐1 receptor agonist therapies in patients with type 1 diabetes (2017) (5)
Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations (2018) (5)
Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance (2016) (5)
Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials (2017) (5)
Insulin-like growth factor-1 is a negative modulator of glucagon secretion (2017) (5)
Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy (2016) (5)
Heart rate affects endothelial function in essential hypertension (2013) (5)
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus (2021) (5)
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia. (2021) (5)
1-h Postload PlasmaGlucose Levels and Left Ventricular Mass in Hypertensive Patients (2011) (4)
Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose (2018) (4)
TRIB 3 R 84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells (2008) (4)
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels (2018) (4)
PTP 1 B deficiency increases glucose uptake in neonatal hepatocytes : involvement of IRA / GLUT 2 complexes (2008) (4)
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
Sex‑specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes. (2022) (4)
Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study (2022) (4)
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea (2022) (4)
Association between Serum Mg2+ Concentrations and Cardiovascular Organ Damage in a Cohort of Adult Subjects (2020) (4)
Hyperglycemia at 1h-OGTT in Pregnancy: A Reliable Predictor of Metabolic Outcomes? (2021) (4)
Erratum: Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet (Journal of Clinical Endocrinology and Metabolism (2005) 90 (5064-5069)) (2005) (4)
Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex (2021) (4)
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study (2022) (4)
The Search for NIDDM genes project: a European Community programme aimed to facilitate the identification of NIDDM genes. (1998) (3)
We-P11:116 Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes mellitus in Caucasian Italian (2006) (3)
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes (2021) (3)
The contribution of unrecognized factors to the diabetes epidemic (2020) (3)
Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes (2022) (3)
Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk (2011) (3)
Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome (2021) (3)
Liraglutide, the once-daily human GLP-1 analog, in the treatment of Type 2 diabetes (2010) (3)
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients (2016) (3)
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action (1990) (3)
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1. (2021) (3)
Multi-disciplinary Consensus Statement Document Vaccinal prevention in adult patients with diabetes mellitus (2018) (3)
Antiphospholipid antibodies and idiopathic infertility (2022) (2)
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals. (2022) (2)
Heart failure and chronic kidney disease in a registry of internal medicine wards (2014) (2)
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance (2023) (2)
Role of Vitamin D in Cardiovascular Diseases (2021) (2)
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. (2022) (2)
Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies (1991) (2)
[Effects of anti-diabetic therapy on overweight/obesity and dyslipidemia: traditional hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) versus glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors]. (2013) (2)
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: the Catanzaro atrial fibrillation project. (2014) (2)
Erratum to: An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics (2010) (2)
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure (2022) (2)
The Gly 972 ® Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic b cells (2018) (2)
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus. (2021) (2)
One-Hour Post-load Glucose is Associated with Severity of Hepatic Fibrosis. (2022) (2)
The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals (2021) (2)
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia (2021) (2)
The evaluation of the intracavitary effusions by a beside ultrasound examination. (2022) (2)
Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN (2021) (2)
Acute Tuberculosis pneumonia and COVID-19 in a patient vaccinated with Bacille Calmette-Guérin (BCG) (2020) (2)
Tu-P7:100 Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients (2006) (1)
[Cardiovascular outcome clinical trials in type 2 diabetes mellitus: what are the epidemiological and methodological evidence and the first evaluations to date?]. (2016) (1)
Effect of mepindolol on blood pressure variability in hypertensive patients (1984) (1)
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes (2021) (1)
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance. (2022) (1)
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes. (2022) (1)
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes (2022) (1)
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome (2023) (1)
[Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors and the cardiovascular system]. (2016) (1)
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus (2020) (1)
Obesity and overweight are linked to increased sodium‐glucose cotransporter 1 and glucose transporter 5 levels in duodenum (2023) (1)
Reciprocal association of plasma insulin-like growth factor-1 and interleukin-6 levels with cardio-metabolic risk factors in nondiabetic subjects (2008) (1)
Effect modification by ferritin on the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance (2020) (1)
Influence of endogenous sex hormones on carotid atherosclerosis in postmenopausal women (2003) (1)
Chronobiological approach to the treatment of essential hypertension: preliminary data. (1984) (1)
Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes". (2018) (1)
One Hour-Post-load Plasma Glucose ≥155 mg/dl in Healthy Glucose Normotolerant Subjects Is Associated With Subcortical Brain MRI Alterations and Impaired Cognition: A Pilot Study (2021) (1)
Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients (2022) (1)
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials (2011) (1)
Consistency of treatment effect across the range of baseline HbA1c in patients with type 2 diabetes mellitus (T2DM) treated with once-weekly dulaglutide or comparators in AWARD-1, -5 and -6 (2016) (1)
Harnessing the weight‐regulating properties of glucagon‐like peptide‐1 in the treatment of type 2 diabetes (2009) (1)
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients (2022) (1)
Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M. (2016) (1)
Association Between a Genetic Variant Related to Glutamic AcidMetabolism and Coronary Heart Disease in IndividualsWith Type 2 Diabetes (2013) (1)
Serum γ-Glutamyltransferase Concentration Predicts Endothelial Dysfunction in Naïve Hypertensive Patients (2020) (1)
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes (2022) (1)
Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders (2003) (1)
The impact of COVID-19 pandemic on well-being of Italian physicians: a report from the Italian Society of Internal Medicine (SIMI) national survey (2022) (1)
[Glucagon-like peptide-1 analogues: effects on body weight and glycemia]. (2010) (1)
Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study for the DARWIN-T2D network (2018) (1)
[Tight glycemic control in the management of diabetic patients: what has changed since the '90s in the clinical approach?]. (2014) (1)
Individualized Therapy for Type 2 Diabetes (2012) (0)
Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study (2018) (0)
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age (2020) (0)
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis (2022) (0)
Insulin Receptor Signalling Apparatus Is Found in Insulin Secretory Granules. Chronic Hyperglycemia Impairs Insulin Receptor Expression and Function in Pancreatic β-Cell (2002) (0)
Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069 (2021) (0)
Author response for "Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of Body Mass Index" (2019) (0)
Tu-W24:6 C-reactive protein impairs glucose transport by inducing phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 muscle cells (2006) (0)
Hyperglycemia induces pro-atherosclerotic events through O-linked-glycosylation modification of insulin signaling proteins (2002) (0)
The Point-of-Care Ultrasound (POCUS) by the Handheld Ultrasound Devices (HUDs) in the COVID-19 Scenario: a Review of the Literature (2022) (0)
[Preparation of 125I-labelled monoclonal antibodies of the insulin receptor]. (1988) (0)
One-hour post-load glucose and subclinical left atrial myocardial dysfunction in hypertensive patients. (2023) (0)
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register. (2023) (0)
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
Subject Index Vol. 43, 1995 (1995) (0)
147-OR: DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice (2019) (0)
In T2D patients with baseline A1c <8.0%, liraglutide achieves A1c targets more often than sitagliptin or exenatide (2013) (0)
A is expressed in endocr ine pancreas and its post-translational product DBI 33 . , 0 inhibits insulin release (0)
91 METABOLIC AND CARDIAC MORPHO-FUNCTIONAL IMPROVEMENTS AFTER PCSK9 INHIBITORS ADMINISTRATION (2022) (0)
Author response for "Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice. The case of GLP‐1 receptor agonists" (2019) (0)
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo (2022) (0)
1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements (2020) (0)
P-84: Distribution of insulin receptor isoforms in the trophoblast of first trimester and term human placenta (2009) (0)
[Combination therapy with glucagon-like peptide-1 analogs and insulin: indications and contraindications in coronary artery disease patients]. (2012) (0)
The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness (2022) (0)
Oral anticoagulant therapy and decline of kidney function in elderly patients with non-valve atrial fibrillation: real world evidence data (2022) (0)
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism (2016) (0)
Late-Breaking Clinical Trial Report (2011) (0)
Post Transplant Hyperuricemia: Incidence and Risk Factors.: Abstract# B905 (2014) (0)
Mo-P6:434 Association between apolipoprotein APOE3/4 genotype and metabolic syndrome (MS) (2006) (0)
Immuno-Mediated Inflammation in Hypertensive Patients with 1-h Post-Load Hyperglycemia (2022) (0)
The phenomenon book of calendars. 1978 - 1979. (1977) (0)
Reply to “Anti-TNF therapy and plasma HDL cholesterol concentration” (2005) (0)
Abbreviated title: Glucose uptake in PTP1B -/- neonatal hepatocytes (2008) (0)
Clinical implications of the biological ambivalence of uric acid. (2023) (0)
[Effects of glucagon-like peptide-1 on appetite and body weight: preclinical and clinical data]. (2011) (0)
P-1405 Glycaemic control improves in type 2 diabetes patients when switching from twice-daily exenatide to once-daily liraglutide (2009) (0)
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients (2022) (0)
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients (2022) (0)
A cc ep te d A rti cl e Cardiovascular Effects of GLP-1 Receptor Agonist Therapies in Patients with Type-1 Diabetes (2017) (0)
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial (2022) (0)
Low-density lipoprotein cholesterol levels are associated with first-phase insulin release. (2023) (0)
93 EFFECT OF SACUBITRIL/VALSARTAN ON ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE (2022) (0)
The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer's disease. (2020) (0)
University of Birmingham Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
Joint Effect of Endothelial Dysfunction and New-onset Diabetes Mellitus in Predicting Cardiovascular Outcomes in Hypertensive Patients: a Cohort Study (2020) (0)
Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease (2022) (0)
A bedside ultrasound protocol to the measurement of the systemic vascular resistances: Preliminary results in the patients with sepsis. (2022) (0)
Mo-W6:4 Interleukin-6 impairs the insulin signaling pathway promoting production of nitric oxide in human umbilical vein endothelial (HUVEC) cells (2006) (0)
ESICON 2019 Abstracts (2019) (0)
2009 SIPREC Consensus Document — Executive Summary (2010) (0)
We-P11:98 Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasian (2006) (0)
ESICON 2019 Abstracts (2019) (0)
Liraglutide achieved greater weight reduction and improved glycaemic control compared with sitagliptin following one-year treatment when both are used in combination with metformin (2011) (0)
The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer’s disease (2021) (0)
We-W34:4 Endothelial dysfunction predicts type 2 diabetes in essential hypertension (2006) (0)
The Gly 3 Arg 972 Amino Acid Polymorphism in Insulin Receptor Substrate-1 Affects Glucose Metabolism in Skeletal Muscle Cells* (2000) (0)
498 Oxidative stress and left ventricular performance in patients according to different glycometabolic phenotypes (2021) (0)
Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’ (2021) (0)
Evidence for Glucose/Hexosamine In Vi v o Regulation of Insulin/IGF-I Hybrid R e c e p t o r A s s e m b l y (1999) (0)
Effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure (2022) (0)
Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance. (2023) (0)
Immune Checkpoints Inhibitors and Diabetes: A Meta-Analysis of Randomized Controlled Trials (2019) (0)
Impact of common polymorphisms in candidate genes on weight loss of morbidly obese subjects (Grade III, WHO) after laparoscopic adjustable gastric banding (LAGB) (2005) (0)
Right Heart Thrombus and Pulmonary Embolism in Patients with Life-Threatening Bleeding: Management of a Complex Condition (2021) (0)
P4571Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation (2017) (0)
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
High prevalence of elevated liver enzymes and glucose intolerance in morbid obese patients are reduced after laparoscopic adjustable gastric banding (LAGB) (2007) (0)
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels (2018) (0)
Current diagnostic criteria identify risk for type 2 diabetes too late. (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giorgio Sesti?

Giorgio Sesti is affiliated with the following schools:

University of Milan
Stanford University
University of Palermo
Magna Græcia University
Sapienza University of Rome